Dermapharm Holding (Germany) Price on December 4, 2024
| DMP Stock | 37.80 0.10 0.26% |
If you're considering investing in Dermapharm Stock, it is important to understand the factors that can impact its price. As of today, the current price of Dermapharm Holding stands at 37.80, as last reported on the 26th of December, with the highest price reaching 37.90 and the lowest price hitting 37.60 during the day. Currently, Dermapharm Holding SE is very steady. Dermapharm Holding secures Sharpe Ratio (or Efficiency) of 0.0704, which denotes the company had a 0.0704% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Dermapharm Holding SE, which you can use to evaluate the volatility of the firm. Please confirm Dermapharm Holding's Mean Deviation of 1.37, coefficient of variation of 1029.16, and Downside Deviation of 1.53 to check if the risk estimate we provide is consistent with the expected return of 0.14%.
Dermapharm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Dermapharm |
Sharpe Ratio = 0.0704
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | DMP | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.01 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Dermapharm Holding is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dermapharm Holding by adding it to a well-diversified portfolio.
Dermapharm Holding Valuation on December 4, 2024
It is possible to determine the worth of Dermapharm Holding on a given historical date. On December 4, 2024 Dermapharm was worth 36.5 at the beginning of the trading date compared to the closed value of 36.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Dermapharm Holding stock. Still, in general, we apply an absolute valuation method to find Dermapharm Holding's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Dermapharm Holding where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Dermapharm Holding's related companies.
| Open | High | Low | Close | Volume | |
| 35.40 | 35.55 | 34.40 | 35.20 | 56,473 | |
12/04/2024 | 36.50 | 37.55 | 35.65 | 36.55 | 101,705 |
| 36.80 | 37.00 | 36.25 | 36.55 | 30,410 |
| Backtest Dermapharm Holding | | | Dermapharm Holding History | | | Dermapharm Holding Valuation | Previous | Next |
Dermapharm Holding Trading Date Momentum on December 4, 2024
| On December 05 2024 Dermapharm Holding SE was traded for 36.55 at the closing time. The highest price during the trading period was 37.00 and the lowest recorded bid was listed for 36.25 . The volume for the day was 30.4 K. This history from December 5, 2024 did not affect price variability. The overall trading delta to the current price is 2.60% . |
Dermapharm Holding Fundamentals Correlations and Trends
By evaluating Dermapharm Holding's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Dermapharm Holding's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Dermapharm financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Dermapharm Holding Stock history
Dermapharm Holding investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Dermapharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Dermapharm Holding will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Dermapharm Holding stock prices may prove useful in developing a viable investing in Dermapharm Holding
Dermapharm Holding Stock Technical Analysis
Dermapharm Holding technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Dermapharm Holding Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Dermapharm Holding SE cannot be verified against its exchange. Please verify the symbol is currently traded on XETRA Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Dermapharm Holding December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Dermapharm Holding stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dermapharm Holding shares will generate the highest return on investment. By undertsting and applying Dermapharm Holding stock market strength indicators, traders can identify Dermapharm Holding SE entry and exit signals to maximize returns
Dermapharm Holding Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Dermapharm Holding's price direction in advance. Along with the technical and fundamental analysis of Dermapharm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Dermapharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0838 | |||
| Jensen Alpha | 0.1895 | |||
| Total Risk Alpha | 0.1 | |||
| Sortino Ratio | 0.1008 | |||
| Treynor Ratio | (10.61) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Dermapharm Stock Analysis
When running Dermapharm Holding's price analysis, check to measure Dermapharm Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermapharm Holding is operating at the current time. Most of Dermapharm Holding's value examination focuses on studying past and present price action to predict the probability of Dermapharm Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermapharm Holding's price. Additionally, you may evaluate how the addition of Dermapharm Holding to your portfolios can decrease your overall portfolio volatility.